NHC · National Healthcare Corp
Market Cap
$3.43B
Shares
15.66M
NHC metrics
89 of 114 screener metrics currently available.
Market overview
2 metricsShare price
$217.34
Market cap
$3.43B
Price action
19 metricsPrice change (1W)
-2.6%
Price change (30D)
-1.7%
Price change (3M)
+19.4%
Price change (6M)
+28.4%
Price change (YTD)
+59.7%
Price change (1Y)
+93.0%
Trailing year
Price change (5Y)
+194.7%
52-week high
$236.75
52-week low
$112.25
Change from 52-week high
-7.5%
Change from 52-week low
+95.1%
Annualized volatility
33.6%
Beta
0.3
RSI (14D)
46.0
Price vs SMA 50
-0.3%
Price vs SMA 200
+25.2%
Avg volume (3M)
130,364
Relative volume
1.0
Average dollar volume
$27.62M
Company
3 metricsSector
Healthcare
Industry
Medical Care Facilities
Shares outstanding
15.66M
Valuation
12 metricsP / E (TTM)
24.6
Trailing earnings · reciprocal yield 4.1%
PEG ratio
0.4
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
2.2×
reciprocal yield 45.5%
P / book
3.1
reciprocal yield 32.7%
FCF yield
4.3%
TTM · current market cap
Buyback yield
0.9%
P / FCF
23.4
reciprocal yield 4.3%
P / operating cash flow
18.2
reciprocal yield 5.5%
Earnings yield
4.1%
Historical valuation
8 metricsP / E historical average (3Y)
19.1×
reciprocal yield 5.2%
P / E historical average (5Y)
21.5×
reciprocal yield 4.7%
EV / revenue historical average (3Y)
1.5×
reciprocal yield 68.5%
EV / revenue historical average (5Y)
1.5×
reciprocal yield 68.5%
EV / EBIT historical average (3Y)
18.8×
reciprocal yield 5.3%
EV / EBIT historical average (5Y)
18.8×
reciprocal yield 5.3%
EV / EBITDA historical average (3Y)
13.4×
reciprocal yield 7.5%
EV / EBITDA historical average (5Y)
13.4×
reciprocal yield 7.5%
Dividends & buybacks
7 metricsDividend yield
1.2%
Trailing 12 months
Payout ratio
28.4%
Shareholder yield
2.1%
Dividend / share (TTM)
$2.59
Dividend growth YoY
+4.9%
Dividend growth streak
5
Last ex-dividend
2026-06-30
Earnings calendar
2 metricsNext earnings
—
Last earnings
—
Profitability
9 metricsGross margin
—
Operating margin
9.3%
Trailing 12 months
Net margin
9.0%
Gross profit (TTM)
—
Operating profit (TTM)
$144.68M
Net income (TTM)
$140.18M
Trailing 12 months
Diluted EPS (TTM)
$8.89
FCF margin
9.4%
Effective tax rate
22.9%
Growth
11 metricsRevenue growth YoY
+8.8%
Year over year
Net income growth YoY
+70.0%
Revenue (TTM)
$1.56B
Trailing 12 months
EPS growth YoY
+67.1%
Shares change YoY
+1.7%
Year over year · more shares
Revenue CAGR (3Y)
+11.8%
Revenue CAGR (5Y)
+8.1%
EPS CAGR (3Y)
+74.2%
EPS CAGR (5Y)
+23.0%
FCF CAGR (3Y)
—
FCF CAGR (5Y)
-3.9%
Quality
14 metricsReturn on equity
12.5%
Return on assets
9.1%
Debt / equity
0.0
Current ratio
1.9
EBITDA (TTM)
$190.40M
Free cash flow (TTM)
$146.53M
Quick ratio
1.8
Interest coverage
56.6
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$39.21M
Total assets
$1.54B
Total debt
$0
Cash flow & spend
7 metricsOperating cash flow (TTM)
$188.81M
Capital expenditures (TTM)
$42.27M
R&D (TTM)
—
SG&A (TTM)
—
Stock compensation (TTM)
$5.41M
R&D / revenue
—
Stock compensation / revenue
0.3%
Ownership (13F)
3 metrics13F filers
252
13F filer change QoQ
+12
Institutional ownership
65.4%
Short interest
3 metricsShort interest
4.8%
Latest settlement · 5.9 days to cover
Days to cover
5.9d
Short-squeeze score
63 / 100
Insider activity
2 metricsNet insider buying (90D)
−$2.26M
Insider-sentiment score
21 / 100
Risk flags
1 metricsGoing concern
—